In a time of growing concern over the politicization of science, biotech leaders across the nation are speaking out with a unified message: decisions surrounding the use and regulation of mifepristone—a key drug in medication abortion—must be grounded in scientific evidence, not ideology.
The biotech and pharmaceutical industries are kicking off 2025 with a fresh wave of mergers and acquisitions (M&A). Johnson & Johnson’s $14.6 2billion acquisition of Intra-Cellular Therapies has set a bold tone, with GSK and Eli Lilly making moves of their own. While optimism is high, factors like rising costs and shifting regulations could shape the pace of deals this year.
Even with these challenges, M&A remains a key strategy for companies looking to stay ahead. With $1.3 trillion in available capital and looming patent expirations that could impact $300 billion in revenue, big pharma is doubling down on strategic acquisitions to fuel future growth. Pfizer, for example, is actively expanding its portfolio to offset potential revenue gaps.
Biotechnology manufacturing is a complex and highly regulated field that demands precision, consistency, and efficiency. To meet these requirements, biotech companies are increasingly turning to advanced automation and control systems. These technologies streamline processes, enhance productivity, and ensure compliance with stringent regulatory standards. Here, we explore some of the most popular automation and control systems used in biotech manufacturing.
The regulatory landscape in biotechnology is constantly changing and evolving – and in turn, new companies must be anticipating these shifts. Proactive steps for regulatory compliance are essential, particularly for start-up companies that are competing with larger, established companies in the market. It is never worth it to skimp on quality or regulatory strategy to move faster. While compliance may seem daunting, emerging biotech companies can easily navigate the intricacies of compliance with the help of EMMA International.
Biotechnology manufacturing is a complex and highly regulated field that demands precision, consistency, and efficiency. To meet these requirements, biotech companies are increasingly turning to advanced automation and control systems. These technologies streamline processes, enhance productivity, and ensure compliance with stringent regulatory standards.
The biotechnology and pharmaceutical industries are heavily reliant on collecting, storing, and analyzing data for...
Preparing New Facilities for GMP Readiness
Preparing New Facilities for GMP Readiness
Preparing New Facilities for GMP Readiness
Preparing New Facilities for GMP Readiness